Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Single-port robotic surgery in gynecologic oncology: feasibility and safety after 1 year of implementation.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026
Same author

Single-port robotic splenectomy in secondary cytoreduction for recurrent high-grade serous ovarian cancer.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026
Same author

Determinants of adjuvant radiotherapy in early-stage cervical cancer: a retrospective analysis of the SUCCOR cohort.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026
Same author

Robotic single-port (da Vinci SP) versus multiport (da Vinci Xi) for the treatment of atypical endometrial hyperplasia and endometrial cancer: A multi-institutional comparison of surgical outcomes.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2025
Same author

Advanced robotic surgery in obese patients with gynecological cancers: tips and tricks from literature to clinical practice.

Journal of robotic surgery·2025
Same author

Effect of conization, manipulator use, and their interaction on recurrence after radical hysterectomy for cervical cancer: A multicenter retrospective analysis.

Gynecologic oncology·2025

Related Experiment Video

Updated: Mar 8, 2026

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
03:07

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial

Published on: August 19, 2025

1.3K

Robot-assisted Surgery in Gynecologic Cancers.

Vanna Zanagnolo1, Annalisa Garbi1, Maria Teresa Achilarre1

  • 1Gynecology Department, European Institute of Oncology, Milan, Italy.

Journal of Minimally Invasive Gynecology
|January 21, 2017
PubMed
Summary

Robotic-assisted surgery offers a minimally invasive approach for gynecologic cancers, showing comparable or improved outcomes versus traditional methods. This technology is safe and effective, especially for complex procedures and obese patients.

Keywords:
Cervical cancerCost-effective analysisEndometrial cancerGynecologic cancersLearning curveMinimally invasive surgeryOvarian cancerRobotic surgery

More Related Videos

Surgical Robot-Assisted Transanal Specimen Extraction Radical Sigmoidectomy Without an Auxiliary Abdominal Incision
07:22

Surgical Robot-Assisted Transanal Specimen Extraction Radical Sigmoidectomy Without an Auxiliary Abdominal Incision

Published on: June 13, 2025

1.2K
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
12:45

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

6.8K

Related Experiment Videos

Last Updated: Mar 8, 2026

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
03:07

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial

Published on: August 19, 2025

1.3K
Surgical Robot-Assisted Transanal Specimen Extraction Radical Sigmoidectomy Without an Auxiliary Abdominal Incision
07:22

Surgical Robot-Assisted Transanal Specimen Extraction Radical Sigmoidectomy Without an Auxiliary Abdominal Incision

Published on: June 13, 2025

1.2K
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
12:45

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

6.8K

Area of Science:

  • Gynecologic Oncology
  • Minimally Invasive Surgery
  • Robotic Surgery

Background:

  • Robotic-assisted surgery (RAS) represents a significant technological advancement in gynecologic oncology.
  • It enables minimally invasive techniques for complex surgical procedures.

Purpose of the Study:

  • To review the existing literature on the role of RAS in treating women with gynecologic cancers.
  • To evaluate the outcomes of RAS compared to conventional surgical approaches.

Main Methods:

  • Literature review of retrospective and descriptive studies on robotic surgery in gynecologic oncology.
  • Analysis of comparative outcomes between robotic-assisted, laparoscopic, and laparotomy approaches.

Main Results:

  • RAS demonstrates comparable or improved outcomes for endometrial cancer, including reduced complications in obese patients.
  • For early cervical cancer, robotic radical hysterectomy appears safe, feasible, and oncologically comparable to laparotomy.
  • Robotic-assisted surgery and laparoscopy show similar outcomes for early-stage ovarian cancer staging, with a shorter learning curve for robotic procedures.
  • RAS is associated with higher costs compared to laparotomy and traditional laparoscopy.

Conclusions:

  • Robotic-assisted surgery facilitates complex gynecologic cancer operations with a minimally invasive approach.
  • While lacking extensive randomized controlled trials, RAS is deemed safe and effective, potentially expanding minimally invasive options for more patients.
  • Further research is needed to confirm oncologic outcome equivalence and impact on quality of life compared to conventional methods.